Interpace Biosciences IDXG
$ 2.84
6.77%
Quarterly report 2024-Q3
added 11-08-2024
Country |
- |
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Jack Stover |
Employees in the company |
176 |
Shares |
4.32 M |
Market Cap[1] |
$ 12.3 M |
EBITDA (LTM) |
$ 3.27 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Diagnostics research"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.